Summary & Overview
HCPCS E0783: Implantable Programmable Infusion Pump System
HCPCS Level II code E0783 identifies an implantable, programmable infusion pump system — the comprehensive device package used to deliver controlled drug infusions for chronic pain management, spasticity, or other long-term medication therapies. Nationally, implantable infusion systems are high-cost durable medical equipment items with implications for device coverage, prior authorization, and site-of-service determinations.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find an overview of coverage considerations and payer-specific approaches, common billing and coding contexts for implantation and device supply, and clinical context explaining why the device is used. The publication summarizes benchmarks for utilization and authorization practices when available and notes where data are not provided.
This resource helps billing professionals, providers, and administrators understand the role of E0783 in claims for implantable infusion therapy, typical settings where the service is delivered, and the policy topics that most affect reimbursement and access for patients receiving implantable programmable pumps.
Billing Code Overview
HCPCS Level II code E0783 describes an implantable, programmable infusion pump system that includes all components such as the pump, catheter, and connectors. The service type is implantable infusion pump therapy, a durable medical device and durable medical equipment service used to deliver continuous or programmable medication infusions.
The typical site of service for E0783 is inpatient or outpatient hospital settings, ambulatory surgical centers, and specialized infusion or procedural suites where surgical implantation and programming of the pump occur. This code covers the complete system as a single billing item rather than individual components.
Clinical & Coding Specifications
Clinical Context
A 56-year-old patient with chronic, intractable cancer-related pain refractory to oral and transdermal opioids is evaluated by a pain management specialist for targeted intrathecal therapy. After multidisciplinary assessment confirming appropriate indications, the patient undergoes implantation of a programmable, implantable infusion pump system to deliver intrathecal analgesics. The clinical workflow includes preoperative evaluation (consent, medication reconciliation, imaging review), device selection and programming, sterile operative implantation of the pump and catheter with intraoperative testing, postoperative device programming and pain control titration, and scheduled refill and maintenance visits for reservoir access and reprogramming. Typical sites of service are the operating room or procedure suite for implantation, and outpatient clinic or ambulatory infusion center for refills, programming, and maintenance.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (standard) | Use when no special circumstance or modifier applies to the service. |
22 | Increased procedural services | Use when the work required to implant the pump is substantially greater than typical (e.g., extensive adhesiolysis). |